Skip to main content
SpringerLink
Log in

Higher insulin prices increase OOP costs despite reduced coverage gap

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tseng CW, et al. Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D. Diabetes Care : 10 Feb 2020. Available from: URL: http://doi.org/10.2337/dc19-1294

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Higher insulin prices increase OOP costs despite reduced coverage gap. PharmacoEcon Outcomes News 847, 12 (2020). https://doi.org/10.1007/s40274-020-6588-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6588-9

Search

Navigation